Prague’s leading knowledge in pharmacoepidemiology has helped it secure the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE 2018).

The event, which will take place in the Prague Congress Centre in the latter half of 2018, is expected to attract some 1,500 physicians, pharmacists, epidemiologists, pharmacologists, statisticians and other professionals to discuss advanced trends in pharmacoepidemiology (P-epi). Bridging clinical pharmacology and epidemiology, P-epi is the study of the utilisation and effects of drugs in large numbers of people. It provides an estimate of the probability of beneficial effects of a drug in a population and the probability of adverse effects, driving policy on prescription, dispensation, distribution and use of medicines.

The Czech Republic has a strong tradition in the field of P-epi and pharmacovigilance. It was one of the pioneer countries in the development of spontaneous reporting systems that joined World Health Organization more than 40 years ago, systematically collecting data in public health. The pharmaceutical industry is a major player in Prague’s economy, and its associated knowledge sector is a leading attraction for conference organisers.

Prague´s conference in 2018 will be held upon invitation of the Faculty of Pharmacy in Hradec Králové represented by Dr Jiří Vlček, one of the Czech Republic’s leading lights in pharmacoepidemiology and clinical pharmacy. He is Head of the Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University, as well as Coordinator of the Social Pharmacy, Clinical Pharmacy and Pharmaceutical History Research Group.

Prague has a successful track record of hosting of other leading conferences in this field in recent years: The European Symposium on Clinical Pharmacy (ESCP) in 2013; The European Society for Patient Adherence, Compliance and Persistence (ESPACOMP) in 2015; and the 15th Annual Meeting of the International Society of Pharmacovigilance (ISoP 2015). The latter event welcomed more than 400 physicians, pharmacists as well as representatives of drug agencies, universities, state authorities, and pharmaceutical industry to an event aimed at raising awareness of drug safety and best practices worldwide. That event was hosted by a local leading knowledge hub, comprising the Charles University in Prague, along with the Czech Pharmaceutical Society under the auspices of Ministry of Health of the Czech Republic and State Institute for Drug Control.

(via ICCA, Prague Convention Bureau)